| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $87.7M | +3.4% |
| Cost of Revenue | $15.0M | +32.0% |
| Gross Profit | $72.7M | -1.0% |
| R&D Expense | $49.0M | -9.6% |
| SG&A Expense | $54.6M | +21.8% |
| Operating Income | -$31.2M | -21.5% |
| Pre-tax Income | -$29.8M | -42.9% |
| Income Tax | -$146K | -126.0% |
| Net Income | -$29.7M | -38.5% |
| EPS (Basic) | -$0.67 | -36.7% |
| EPS (Diluted) | -$0.67 | -36.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.2M | -14.5% |
| Accounts Receivable | $19.7M | -12.3% |
| Inventory | $7.2M | +42.4% |
| Current Assets | $98.5M | -11.3% |
| Total Assets | $119.9M | -6.2% |
| Current Liabilities | $23.7M | +17.7% |
| Total Liabilities | $27.9M | +3.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.7M | +42.3% |
| Financing Cash Flow | $4.3M | +4211.0% |
| Stockholders' Equity |
| $92.0M |
| -8.9% |